Smoking Habits of Patients Undergoing Treatment for Intermittent Claudication in the Vascular Quality Initiative

• Published in: Annals of vascular surgery Vol. 44; pp. 261 - 268
• Main Authors: Gabel, Joshua, Jabo, Brice, Patel, Sheela, Kiang, Sharon, Bianchi, Christian, Chiriano, Jason, Teruya, Theodore, Abou-Zamzam, Ahmed M
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.10.2017
• Subjects: Age Factors; Aged; Ankle Brachial Index; Comorbidity; Female; Habits; Humans; Intermittent Claudication - diagnosis; Intermittent Claudication - epidemiology; Intermittent Claudication - surgery; Male; Middle Aged; Peripheral Arterial Disease - diagnosis; Peripheral Arterial Disease - epidemiology; Peripheral Arterial Disease - surgery; Prevalence; Registries; Risk Factors; Sex Factors; Smokers - psychology; Smoking - adverse effects; Smoking - epidemiology; Smoking - psychology; Smoking Cessation - psychology; Surgery; Time Factors; United States - epidemiology
• ISSN: 0890-5096; 1615-5947
• DOI: 10.1016/j.avsg.2017.04.046

Background Society for Vascular Surgery practice guidelines for the medical treatment of intermittent claudication give a GRADE 1A recommendation for smoking cessation. Active smoking is therefore expected to be low in patients suffering from intermittent claudication selected for vascular surgical intervention. The aim of this study is to evaluate the prevalence of smoking in patients undergoing intervention for intermittent claudication at the national level and to determine the relationship between smoking status and intervention. Methods The Vascular Quality Initiative (VQI) registries for infra-inguinal bypass, supra-inguinal bypass, and peripheral vascular intervention (PVI) were queried to identify patients who underwent invasive treatment for intermittent claudication. Patient factors, procedure type (bypass versus PVI), and level of disease (supra-inguinal versus infra-inguinal) were evaluated for associations with smoking status (active smoking or nonsmoking) by univariate and covariate analysis. Results Between 2010 and 2015, 101,055 procedures were entered in the 3 registries, with 40,269 (40%) performed for intermittent claudication. Complete data for analysis were present in 37,632 cases. At the time of intervention, 44% of patients were active smokers, with wide variation by regional quality group (16–53%). In covariate analysis, active smoking at treatment was associated with age <70 years (prevalence ratio [PR] 2.42), male gender (PR 1.03), chronic obstructive pulmonary disease (PR 1.35), absence of prior cardiovascular procedures (PR 1.15), poor medication usage (PR 1.10), preoperative ankle-brachial index (ABI) <0.9 (PR 1.19), and supra-inguinal disease (PR 1.14). Invasiveness of treatment (PVI versus bypass procedures) was not significantly associated with smoking status. During follow-up, 36% of patients had quit smoking. Predictors of smoking cessation included age ≥70 years (RR 1.45), ABI ≥0.9 (RR 1.12), and bypass procedures (RR 1.22). Conclusions At the time of treatment, 44% of patients undergoing intervention for intermittent claudication in the VQI were active smokers and there was a wide regional variation. Prevalence of active smoking was greater in the presence of younger age, fewer comorbidities, lower ABI, and supra-inguinal disease. Type of procedure performed, and in turn level of invasiveness required, did not appear to be influenced by smoking status. Elderly patients and those undergoing open procedures were more likely to quit smoking during follow up. These findings suggest opportunities for greater smoking cessation efforts before invasive therapies for intermittent claudication.